Human Data Map Two Failure Modes for Allogeneic CAR-T

Company Allogene Therapeutics Event Type Publication / Peer-Reviewed Study Modality Allogeneic CAR-T Cell Therapy Asset Cemacabtagene ansegedleucel (cema-cel) Target CD19 Disease Area Large B-Cell Lymphoma Summary A peer-reviewed Cancer Discovery study evaluated 11 large B-cell lymphoma patients who received one lot of cemacabtagene ansegedleucel and…